The DOI matches its Crossref record; 86 of the 93 references it cites were found in a registry or an index.
Proautophagic Drugs: A Novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe the pathways involved in the natural resistance of cancer cells to cytotoxic insults including radio-/chemotherapy.Explain autophagic cell death as a potent alternative tumor-suppressing mechanism.Identify the common targets in apoptosis and autophagy resistance pathways and the surrogate markers that could be used in clinical practice for proautophagic therapy.Discuss the rationale for incorporating endoplasmic reticulum stress inhibitors as adjuvant chemotherapies against apoptosis-resistant cancers. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As the suppression of autophagy to sustain the cytotoxicity of chemotherapeutic drugs is a novel strategy for cancer chemotherapy3435, HDAC10 is an emerging target for the treatment of advanced-stage neuroblastoma32.”
From Histone deacetylase 10 structure and molecular function as a polyamine deacetylase (2017) · cites this paper as [35]
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Self-eating and self-killing: crosstalk between autophagy and apoptosis
Maiuri, M. C., Zalckvar, E., Kimchi, A., & Kroemer, G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2239 · Cited by 3,638
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033 · cited 1×
“The autophagy story began in 1966 when De Duve and Wattiaux [ 28 ] discovered lysosomes, with the significance that autophagy is a lysosome-mediated degradation of proteins and cellular organelles [27].”
BackgroundAutophagy in Health and Disease: A Double-Edged Sword
Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,559
The role of autophagy in cancer development and response to therapy
Kondo, Y., Kanzawa, T., Sawaya, R. A., & Kondo, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1692 · Cited by 1,673
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,586
Growth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
Autophagy as a cell death and tumor suppressor mechanism
Gözüaçık, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,396
Cited by
Sorted by citations
Items 101–200 of 238
Luk, S. K., Piekorz, R. P., Nürnberg, B., & To, S. S. T. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.006 · Cited by 44
Ulukaya, E., Frame, F. M., Cevatemre, B., Pellacani, D., Walker, H. F., Mann, V. M., Simms, M. S., Stower, M. J., Yılmaz, V. T., & Maitland, N. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064278 · Cited by 44
Anticancer Activity of Curcumin-Loaded PLGA Nanoparticles on PC3 Prostate Cancer Cells.
Azandeh, S., Abbaspour, M., Khodadadi, A., Khorsandi, L., Orazizadeh, M., & Heidari-Moghadam, A. (2017) · Europe PMC (PubMed Central) · Cited by 44
In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy
Wauthoz, N., Deleuze, P., Hecq, J., Roland, I. H., Saussez, S., Adanja, I., Debeir, O., Decaestecker, C., Mathieu, V., Robert Kiss, A., et al. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.01.010 · Cited by 43
Autophagy‐mediated chemosensitization by cysteamine in cancer cells
Wan, X., Zheng, F., Zhang, L., Miao, Y., Man, N., & Wen, L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25771 · Cited by 42
Lallemand, B., Chaix, F., Bury, M., Bruyère, C., Ghostin, J., Becker, J., Delporte, C., Gelbcke, M., Mathieu, V., Dubois, J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200285z · Cited by 42
Temozolomide-Based Dry Powder Formulations for Lung Tumor-Related Inhalation Treatment
Wauthoz, N., Deleuze, P., Saumet, A., Duret, C., Robert Kiss, A., & Amighi, K. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0329-x · Cited by 42
LIU, B., Gao, Y., Wang, X., WANG, Y.-C., & Fu, L. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2290 · Cited by 41
Essential Oil from Arnica Montana L. Achenes: Chemical Characteristics and Anticancer Activity
Sugier, D., Sugier, P., Jakubowicz-Gil, J., Winiarczyk, K., & Kowalski, R. (2019) · Molecules · doi:10.3390/molecules24224158 · Cited by 41
Neurotransmitters: Potential Targets in Glioblastoma
Huang, Q., Chen, L., Liang, J., Huang, Q., & Sun, H. (2022) · Cancers · doi:10.3390/cancers14163970 · Cited by 44
Azad, M. B., & Gibson, S. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05778.x · Cited by 41
Involvement of estrogen receptor β5 in the progression of glioma
Li, W., Winters, A., Poteet, E. C., Ryou, M., Lin, S., Hao, S., Wu, Z., Yuan, F., Hatanpaa, K. J., Simpkins, J. W., et al. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.004 · Cited by 38
Algae metabolites: from in vitro growth inhibitory effects to promising anticancer activity
Lefranc, F., Koutsaviti, A., Ioannou, E., Kornienko, A., Roussis, V., Robert Kiss, A., & Newman, D. J. (2018) · Natural Product Reports · doi:10.1039/c8np00057c · Cited by 36
Self-citationNuzzo, G., Ciavatta, M. L., Robert Kiss, A., Mathieu, V., Leclercqz, H., Manzo, E., Villani, G., Mollo, E., Lefranc, F., D’Souza, L., et al. (2012) · Marine Drugs · doi:10.3390/md10081799 · Cited by 38
Self-citationLee, S. W., Kim, S. M., Hur, W., Kang, B.-Y., Lee, H. L., Nam, H., Yoo, S. H., Sung, P. S., Kwon, J. H., Jang, J. W., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261067 · Cited by 40
PML-RAR&x03B1; enhances autophagic activity through inhibiting Akt/mTOR pathwayPreprint
Huang, Y., Hou, J., Chen, T., Zhao, X.-Y., Yan, Z.-W., Zhang, J., Yang, J., Kogan, S. C., & Chen, G. (2010) · Nature Precedings · doi:10.4161/auto.7.10.16636 · Cited by 39
Shen, Y., Yuan, Y., Du, Y., & PAN, Y.-Y. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3411 · Cited by 36
Ferreira, J. S. P. D. M., Ramos, A. A., Almeida, T., Azqueta, A., & Rocha, E. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.04.062 · Cited by 35
Histone deacetylase 5 promotes the proliferation of glioma cells by upregulation of Notch 1
Liu, Q., Zheng, J., CHEN, J.-K., Yan, X., Chen, H., Nong, W., & Huang, H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2395 · Cited by 35
LAT1 targeted brain delivery of temozolomide and sorafenib for effective glioma therapy
Zhang, Y., Cheng, Q., Xue, Y., Yao, K., Syeda, M. Z., Xu, J., Wu, J., Wang, Z., Tang, L., & Mu, Q. (2023) · Nano Research · doi:10.1007/s12274-023-5568-3 · Cited by 34
Lam, M. S. Y., Aw, J., Tan, D., Vijayakumar, R., Lim, H. Y. G., Yada, S., Pang, Q. Y., Barker, N., Tang, C., Ang, B. T., et al. (2023) · Small · doi:10.1002/smll.202302280 · Cited by 34
Mechanisms of autophagy and apoptosis: Recent developments in breast cancer cells
Esteve, J. M. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i10.232 · Cited by 35
Goffin, E., Lamoral‐Theys, D., Tajeddine, N., Tullio, P. D., Mondin, L., Lefranc, F., Gailly, P. L., Rogister, B., Robert Kiss, A., & Pirotte, B. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.050 · Cited by 31
Self-citationFerrucci, M., Biagioni, F., Lenzi, P., Gambardella, S., Ferese, R., Calierno, M. T., Falleni, A., Grimaldi, A., Frati, A., Esposito, V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15906 · Cited by 31
Li, K., Liang, N., Yang, H., Liu, H., & Li, S. (2017) · Oncotarget · doi:10.18632/oncotarget.22791 · Cited by 31
Sugier, P., Jakubowicz-Gil, J., Sugier, D., Kowalski, R., Gawlik‐Dziki, U., Kołodziej, B., & Dziki, D. (2020) · Molecules · doi:10.3390/molecules25061284 · Cited by 31
Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior
Lefranc, F. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i9.193 · Cited by 30
Self-citationMitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells
Macchioni, L., Davidescu, M., Sciaccaluga, M., Marchetti, C., Migliorati, G., Coaccioli, S., Roberti, R., Corazzi, L., & Castigli, E. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9375-2 · Cited by 30
Mora-Rodríguez, R. A., & Régnier‐Vigouroux, A. (2009) · Autophagy · doi:10.4161/auto.5.3.7881 · Cited by 30
Ferese, R., Lenzi, P., Fulceri, F., Biagioni, F., Fabrizi, C., Gambardella, S., Familiari, P., Frati, A., Limanaqi, F., & Fornai, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134570 · Cited by 29
Szeliga, M., Zgrzywa, A., Obara‐Michlewska, M., & Albrecht, J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07917.x · Cited by 28
The potential roles of dopamine in malignant glioma
Lan, Y., Wang, X., Xing, J., Lou, J., Ma, X., & Zhang, B. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0730-2 · Cited by 28
The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer
Leisching, G. R., Loos, B., Botha, M. H., & Engelbrecht, A. (2015) · Toxicology · doi:10.1016/j.tox.2015.07.010 · Cited by 27
Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues
Othman, E. Q. G., Kaur, G., Mutee, A. F., Muhammad, T. S. T., & Tan, M. (2009) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20309 · Cited by 27
Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype
Szeliga, M., & Albrecht, J. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.11.004 · Cited by 26
Paul-Samojedny, M., Pudełko, A., Kowalczyk, M., Fila-Daniłow, A., Suchanek-Raif, R., Borkowska, P., & Kowalski, J. (2016) · BioDrugs · doi:10.1007/s40259-016-0160-y · Cited by 26
Considering temozolomide as a novel potential treatment for esophageal cancer
Bruyère, C., Lonez, C., Duray, A., Cludts, S., Ruysschaert, J., Saussez, S., Yeaton, P., Robert Kiss, A., & Mijatovic, T. (2010) · Cancer · doi:10.1002/cncr.25687 · Cited by 27
Li, X., Cen, Y., Cai, Y., Liu, T., Liu, H., Cao, G., Liu, D., Li, B., Wei, P., Zou, J., et al. (2016) · Scientific Reports · doi:10.1038/srep27104 · Cited by 26
Chapter 14 Autophagy in Lung Cancer
Jaboin, J. J., Hwang, M., & Lu, J. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)04014-7 · Cited by 26
NETRIN-4 Protects Glioblastoma Cells FROM Temozolomide Induced Senescence
Li, L., Hu, Y., Ylivinkka, I., Li, H., Chen, P., Keski‐Oja, J., & Hyytiäinen, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080363 · Cited by 26
Redox Regulation of Autophagy in Cancer: Mechanism, Prevention and Therapy
He, J., Dong, L., Luo, L., & Wang, K. (2022) · Life · doi:10.3390/life13010098 · Cited by 26
Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells
Jakubowicz-Gil, J., Langner, E., & Rzeski, W. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70506-0 · Cited by 25
Can hsp90α-Targeted siRNA Combined With TMZ Be a Future Therapy for Glioma?
Cruickshanks, N. A., Shervington, L. A., Patel, R., Munje, C., Thakkar, D., & Shervington, A. A. (2010) · Cancer Investigation · doi:10.3109/07357901003630967 · Cited by 25
Ghosh, S., Sikdar, S., Mukherjee, A., & Khuda‐Bukhsh, A. R. (2015) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(15)60156-x · Cited by 25
Necroptosis: A novel therapeutic target for glioblastoma
Jiang, Y., Peng, Y., & Koussougbo, K. S. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.10.037 · Cited by 25
Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro.
Gao, S., Yang, X., Zhang, W.-G., Ji, Y., & Pan‐Hammarström, Q. (2009) · PubMed · Cited by 25
Rosière, R., Gelbcke, M., Mathieu, V., Antwerpen, P. V., Amighi, K., & Wauthoz, N. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3092 · Cited by 24
Taxifolin Targets PI3K and mTOR and Inhibits Glioblastoma Multiforme
Yao, W., Gong, H., Mei, H., Shi, L., Yu, J., & Hu, Y. (2021) · Journal of Oncology · doi:10.1155/2021/5560915 · Cited by 24
CHEN, C.-M., Syu, J.-P., Way, T., Huang, L., Kuo, S., Lin, C., & Lin, C. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2332 · Cited by 24
Modulating autophagy: a strategy for cancer therapy
Li, J.-L., Han, S., & Fan, X. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10185 · Cited by 23
Lobo, M. R., Green, S. C., Schabel, M. C., Gillespie, G. Y., Woltjer, R. L., & Pike, M. M. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not119 · Cited by 23
Altmeyer, A., Jung, A. C., Ignat, M., Benzina, S., Denis, J.-M., Gueulette, J., Noël, G., Mutter, D., & Bischoff, P. L. (2010) · PubMed · Cited by 22
The Anticancer Activity of Monosaccharides: Perspectives and Outlooks
McCallum, N., & Najlah, M. (2024) · Cancers · doi:10.3390/cancers16162775 · Cited by 21
Albanese, C., Alzani, R., Amboldi, N., Degrassi, A., Festuccia, C., Fiorentini, F., Gravina, G. L., Mercurio, C., Pastori, W., Brasca, M. G., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12112 · Cited by 22
Davidescu, M., Sciaccaluga, M., Macchioni, L., Angelini, R., Lopalco, P., Rambotti, M. G., Roberti, R., Corcelli, A., Castigli, E., & Corazzi, L. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9411-x · Cited by 21
Chen, J.-C., Hwang, J.-H., Chiu, W.-H., & Chan, Y. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.902974 · Cited by 21
Cho, H. R., Kumari, N., Thakur, N., Vu, H. T., Kim, H., & Choi, S. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-53147-9 · Cited by 20
Ooi, K. L., Muhammad, T. S. T., Lim, C. H., & Sulaiman, S. F. (2010) · Integrative Cancer Therapies · doi:10.1177/1534735409356443 · Cited by 20
Li, S.-H., Huang, E., Lu, H., Huang, W., Yen, C., Huang, W., & Chen, C. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.06.049 · Cited by 20
Is there a common upstream link for autophagic and apoptotic cell death in human high-grade gliomas?
Emdad, L., Qadeer, Z. A., Bederson, L., Kothari, H. P., Uzzaman, M., & Germano, I. M. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor053 · Cited by 20
Potential anticancer activity of young Carpinus betulus leaves
Cieckiewicz, E., Angenot, L. J. G., Gras, T., Robert Kiss, A., & Frédérich, M. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.09.072 · Cited by 20
Xiong, J., Cheng, G., Tang, H., Zhen, H., & Zhang, X. (2008) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2008.11.008 · Cited by 19
Characterization and comparison of perezone with some analogues. Experimental and theoretical study
Escobedo-González, R. G., Córdova-Bahena, L., Tellez, J. L. A., Hinojosa-Torres, J., Ruvalcaba, R. M., & Aceves-Hernández, J. M. (2015) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2015.05.016 · Cited by 19
Lefranc, F., Xu, Z., Burth, P., Mathieu, V., Revelant, G., Faria, M. V. D. C., Noyon, C., Garcia, D. G., Dufour, D., Bruyère, C., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.046 · Cited by 20
Self-citationBruyère, C., Madonna, S., Goietsenoven, G. V., Mathieu, V., Dessolin, J., Kraus, J., Lefranc, F., & Robert Kiss, A. (2011) · Translational Oncology · doi:10.1593/tlo.10253 · Cited by 18
Self-citationYu, Q., Liu, L., Wang, P., Yao, Y., Xue, Y., & Liu, Y. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1315492 · Cited by 17
Perezone and its isomer isoperezone induce caspase-dependent and caspase-independent cell death
Sánchez‐Torres, L. E., Martínez, J. O., Godínez‐Victoria, M., Omar, J., & Velasco‐Bejarano, B. (2010) · Phytomedicine · doi:10.1016/j.phymed.2009.12.011 · Cited by 17
Ciechomska, I. A. (2018) · Postępy Biochemii · doi:10.18388/pb.2018_121 · Cited by 16
Ooi, K. L., Muhammad, T. S. T., & Sulaiman, S. F. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.12.032 · Cited by 16
Cell death after high-LET irradiation in orthotopic human hepatocellular carcinoma in vivo.
Altmeyer, A., Ignat, M., Denis, J.-M., Messaddeq, N., Gueulette, J., Mutter, D., & Bischoff, P. L. (2011) · PubMed · Cited by 16
Han, L., Zhang, Y., Liu, S., Zhao, Q., Liang, X., Ma, Z., Gupta, P. K., Zhao, M., & Wang, A. (2017) · Oncotarget · doi:10.18632/oncotarget.22594 · Cited by 16
Lamoral‐Theys, D., Wauthoz, N., Heffeter, P., Mathieu, V., Jungwirth, U., Lefranc, F., Nève, J., Dubois, J., Dufrasne, F., Amighi, K., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01403.x · Cited by 15
Self-citationSung, E., Kim, J., Ahn, Y. T., Lee, I., Choi, S., Jang, H. B., Lee, J., & An, W. G. (2020) · Anticancer Research · doi:10.21873/anticanres.14650 · Cited by 15
Amer, E. I., Eissa, M. M., & Mossallam, S. F. (2014) · Journal of Parasitic Diseases · doi:10.1007/s12639-014-0529-0 · Cited by 15
The anti-tumor effects of Celastrus orbiculatus Thunb. and its monomer composition: A review
Feng, X., Yin, Z., Ou, S., Chu, Z., Feng, J., Luo, Y., Hu, Y., Liu, Y., Jiang, W., Wang, X., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116363 · Cited by 16
Paul-Samojedny, M., Pudełko, A., Kowalczyk, M., Fila-Daniłow, A., Suchanek-Raif, R., Borkowska, P., & Kowalski, J. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.04.012 · Cited by 14
Kritikou, I., Giannopoulou, E., Koutras, A. K., Labropoulou, V., & Kalofonos, H. P. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.841718 · Cited by 14
Hiratsuka, T., Inomata, M., Kono, Y., Yokoyama, S., Shiraishi, N., & Kitano, S. (2013) · Oncology Reports · doi:10.3892/or.2013.2394 · Cited by 13
Ortiz-Rivera, J., Nuñez, R. E., Kucheryavykh, Y. V., & Kucheryavykh, L. Y. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04260-3 · Cited by 12
Gui, C., Cao, J., Tan, L., Huang, Y., Tang, Y., Li, P.-J., Chen, Y., Lu, J. K., Yao, H., Chen, Z., et al. (2021) · Genomics · doi:10.1016/j.ygeno.2021.01.016 · Cited by 12
Lobo, M. R., Wang, X., Gillespie, G. Y., Woltjer, R. L., & Pike, M. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114110 · Cited by 12
Innovative Therapies against Human Glioblastoma Multiforme
Cimini, A., & Ippoliti, R. (2011) · ISRN Oncology · doi:10.5402/2011/787490 · Cited by 11
RetractedPonte‐Sucre, A., Gulder, T., Gulder, T. A. M., Vollmers, G., Bringmann, G., & Moll, H. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.014241-0 · Cited by 11
Witusik‐Perkowska, M., Zakrzewska, M., Sikorska, B., Papierz, W., Jaskólski, D. J., Szemraj, J., & Liberski, P. P. (2017) · Bioscience Reports · doi:10.1042/bsr20170058 · Cited by 11
Role of Autophagy in the Ovary Cell Death in Mammals
Escobar, M. L., Echeverría, O. M., & Vázquez‐Nin, G. H. (2013) · InTech eBooks · doi:10.5772/54777 · Cited by 10
Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas
Lefranc, F. (2009) · Acta Neurochirurgica · doi:10.1007/s00701-009-0185-9 · Cited by 10
Self-citationCalcium dependence of purinergic subtype P2Y1 receptor modulation of C6 glioma cell migration
Jantaratnotai, N., & McLarnon, J. G. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.04.034 · Cited by 9
Wang, J., Qin, C., Chen, Z., Wen, Y. H., Ke, S., & Liao, B. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00077-8 · Cited by 9
Pan, J., Zhou, L., Wang, G., XIA, G.-W., Xue, K., Cui, X., SHI, H.-Z., Liu, J., & Hu, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3213 · Cited by 8
Al‐Huseini, I., Sirasanagandla, S. R., Babu, K. S., Sofin, R. G. S., & Das, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220117114306 · Cited by 8
Beclin (2010) · International Journal of Oncology · doi:10.3892/ijo_00000798 · Cited by 8
Han, B., & Lee, M. (2015) · International Journal of Pharmacology · doi:10.3923/ijp.2016.19.27 · Cited by 8
Stachyra, P., & Grzybowska-Szatkowska, L. (2025) · Genes · doi:10.3390/genes16050600 · Cited by 8
Kiss (2010) · International Journal of Oncology · doi:10.3892/ijo_00000842 · Cited by 7
Zhang, J., Lian, H., Chen, K., Pang, Y. K., Chen, M., Huang, B., Zhu, L., Xu, S., Liu, M., & Zhong, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714868 · Cited by 7
Lan, Y., Yu, Z., Lou, J., Ma, X., & Zhang, B. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1512582 · Cited by 6
Autophagy, new perspectives in anticancer therapy
Lisiak, N., Totoń, E., & Rybczyńska, M. (2014) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1111361 · Cited by 6
Targeted therapy of glioblastomas: a 5-year view
Djedid, R., Robert Kiss, A., & Lefranc, F. (2009) · Therapy · doi:10.2217/thy.09.12 · Cited by 6
Self-citationAutophagy: A strategy for malignant gliomas’ resistance to therapy
Ge, P., Luo, Y., Fu, S., Ji, X., & Ling, F. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.11.047 · Cited by 6
Autophagy-mediated growth inhibition of malignant glioma cells by the BH3-mimetic gossypol
Kim, N.-Y., & Lee, M. (2014) · Molecular & Cellular Toxicology · doi:10.1007/s13273-014-0017-8 · Cited by 5
Metadata
- Authors
- Lefranc, F., Facchini, V., & Kiss, R.
- Affiliations
- Université Libre de Bruxelles (BE)
- c Unibioscreen SA, Brussels, Belgium
- b Laboratory of Toxicology, Institute of Pharmacy, Université Libre de Bruxelles, Brussels, Belgium
- Corresponding author
- Lefranc, Florence
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-01
- Volume
- 12
- Issue
- 12
- Pages
- 1395-1403
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2099551830
- Cited by
- 237
- References
- 93
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 7 · 2018: 11 · 2017: 14 · 2016: 10 · 2015: 13 · 2014: 13 · 2013: 21 · 2012: 19
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Oncologist (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- autophagic cell death, apoptosis resistance, glioblastoma, temozolomide, mTOR inhibitors, PI3K/Akt signaling, endoplasmic reticulum stress, combination chemotherapy, caspase-independent cell death
- MeSH terms
- Temozolomide, Antineoplastic Agents, Autophagy, Dacarbazine, Glioblastoma, Humans, Neoplasms, Drug Delivery Systems, Apoptosis, Drug Resistance, Neoplasm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review